Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

biomarker

  • Open Access
    SV2A PET imaging is a non-invasive marker for the detection of spinal damages in experimental models of spinal cord injury
    Daniele Bertoglio, Nicolas Halloin, Stef De Lombaerde, Aleksandar Jankovski, Jeroen Verhaeghe, Charles Nicaise and Steven Staelens
    Journal of Nuclear Medicine January 13, 2022, jnumed.121.263222; DOI: https://doi.org/10.2967/jnumed.121.263222
  • Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
    You have access
    Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
    David L. Chan, Gary A. Ulaner, David Pattison, David Wyld, Rahul Ladwa, Julian Kirchner, Bob T. Li, W. Victoria Lai, Nick Pavlakis, Paul J. Roach and Dale L. Bailey
    Journal of Nuclear Medicine September 1, 2021, 62 (9) 1278-1284; DOI: https://doi.org/10.2967/jnumed.120.257659
  • Measurement of PET Quantitative Bias In Vivo
    You have access
    Measurement of PET Quantitative Bias In Vivo
    Martin A. Lodge, Wojciech Lesniak, Michael A. Gorin, Kenneth J. Pienta, Steven P. Rowe and Martin G. Pomper
    Journal of Nuclear Medicine May 10, 2021, 62 (5) 732-737; DOI: https://doi.org/10.2967/jnumed.120.251397
  • You have access
    Data-Driven Prioritization and Review of Targets for Molecular-Based Theranostic Approaches in Pancreatic Cancer
    Marjory Koller, Elmire Hartmans, Derk Jan A. de Groot, Xiao Juan Zhao, Gooitzen M. van Dam, Wouter B. Nagengast and Rudolf S.N. Fehrmann
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 1899-1903; DOI: https://doi.org/10.2967/jnumed.117.198440
  • You have access
    89Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma
    Suzanne C. van Es, Adrienne H. Brouwers, Shekar V.K. Mahesh, Annemarie M. Leliveld-Kors, Igle J. de Jong, Marjolijn N. Lub-de Hooge, Elizabeth G.E. de Vries, Jourik A. Gietema and Sjoukje F. Oosting
    Journal of Nuclear Medicine June 1, 2017, 58 (6) 905-910; DOI: https://doi.org/10.2967/jnumed.116.183475
  • You have access
    Preclinical Evaluation of 18F-JNJ64349311, a Novel PET Tracer for Tau Imaging
    Lieven Declercq, Frederik Rombouts, Michel Koole, Katleen Fierens, Jonas Mariën, Xavier Langlois, José Ignacio Andrés, Mark Schmidt, Gregor Macdonald, Diederik Moechars, Wim Vanduffel, Thomas Tousseyn, Rik Vandenberghe, Koen Van Laere, Alfons Verbruggen and Guy Bormans
    Journal of Nuclear Medicine June 1, 2017, 58 (6) 975-981; DOI: https://doi.org/10.2967/jnumed.116.185199
  • You have access
    Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain
    Nabeel B. Nabulsi, Joël Mercier, Daniel Holden, Stephane Carré, Soheila Najafzadeh, Marie-Christine Vandergeten, Shu-fei Lin, Anand Deo, Nathalie Price, Martyn Wood, Teresa Lara-Jaime, Florian Montel, Marc Laruelle, Richard E. Carson, Jonas Hannestad and Yiyun Huang
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 777-784; DOI: https://doi.org/10.2967/jnumed.115.168179
  • You have access
    TBCRC 008: Early Change in 18F-FDG Uptake on PET Predicts Response to Preoperative Systemic Therapy in Human Epidermal Growth Factor Receptor 2–Negative Primary Operable Breast Cancer
    Roisin M. Connolly, Jeffrey P. Leal, Matthew P. Goetz, Zhe Zhang, Xian C. Zhou, Lisa K. Jacobs, Joyce Mhlanga, Joo H O, John Carpenter, Anna Maria Storniolo, Stanley Watkins, John H. Fetting, Robert S. Miller, Kostandinos Sideras, Stacie C. Jeter, Bridget Walsh, Penny Powers, Jane Zorzi, Judy C. Boughey, Nancy E. Davidson, Lisa A. Carey, Antonio C. Wolff, Nagi Khouri, Edward Gabrielson, Richard L. Wahl and Vered Stearns
    Journal of Nuclear Medicine January 1, 2015, 56 (1) 31-37; DOI: https://doi.org/10.2967/jnumed.114.144741
  • You have access
    Everolimus Reduces 89Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors
    Sophie J. van Asselt, Sjoukje F. Oosting, Adrienne H. Brouwers, Alfons H.H. Bongaerts, Johan R. de Jong, Marjolijn N. Lub-de Hooge, Thijs H. Oude Munnink, Helle-Brit Fiebrich, Wim J. Sluiter, Thera P. Links, Annemiek M.E. Walenkamp and Elisabeth G.E. de Vries
    Journal of Nuclear Medicine July 1, 2014, 55 (7) 1087-1092; DOI: https://doi.org/10.2967/jnumed.113.129056
  • You have access
    Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association
    Keith A. Johnson, Satoshi Minoshima, Nicolaas I. Bohnen, Kevin J. Donohoe, Norman L. Foster, Peter Herscovitch, Jason H. Karlawish, Christopher C. Rowe, Maria C. Carrillo, Dean M. Hartley, Saima Hedrick, Virginia Pappas and William H. Thies
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 476-490; DOI: https://doi.org/10.2967/jnumed.113.120618

Pages

  • Next
  • 1
  • 2
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire